SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-18-174218
Filing Date
2018-05-25
Accepted
2018-05-25 06:39:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d595886dsc13d.htm SC 13D 64542
  Complete submission text file 0001193125-18-174218.txt   66236
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filed by) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address TECHNOLOGIEPARK 21 ZWIJNAARDE GHENT C9 9052
Business Address TECHNOLOGIEPARK 21 ZWIJNAARDE GHENT C9 9052 003292620000
Ablynx NV (Subject) CIK: 0001617582 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90201 | Film No.: 18859619
SIC: 2836 Biological Products, (No Diagnostic Substances)